A functional genomics approach to identify pathways of drug resistance in medulloblastoma

被引:11
|
作者
Bertrand, Kelsey C. [1 ,2 ,3 ]
Faria, Claudia C. [4 ]
Skowron, Patryk [5 ,6 ,7 ,8 ]
Luck, Amanda [5 ,6 ,7 ,8 ]
Garzia, Livia [5 ,6 ,7 ,8 ]
Wu, Xiaochong [5 ,6 ,7 ,8 ]
Agnihotri, Sameer [9 ]
Smith, Christian A. [5 ,6 ,7 ,8 ]
Taylor, Michael D. [5 ,6 ,7 ,8 ]
Mack, Stephen C. [1 ,2 ,3 ]
Rutka, James T. [5 ,6 ,7 ,8 ]
机构
[1] Baylor Coll Med, Dept Pediat, Div Hematol & Oncol, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Canc Ctr, Brain Tumor Program, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Hematol Ctr, Brain Tumor Program, Houston, TX 77030 USA
[4] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Dept Neurosurg, EPE, Lisbon, Portugal
[5] Hosp Sick Children, Dept Dev & Stem Cell Biol & Regenerat Med, Toronto, ON, Canada
[6] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON, Canada
[7] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[8] Hosp Sick Children, Dept Neurosurg, Toronto, ON, Canada
[9] Univ Pittsburgh, Childrens Hosp, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA
来源
ACTA NEUROPATHOLOGICA COMMUNICATIONS | 2018年 / 6卷
基金
美国国家卫生研究院;
关键词
Cancer; Brain tumor; Medulloblastoma; Drug resistance; Functional genomics; Transposon mutagenesis; Sleeping beauty; MOLECULAR SUBGROUPS; LANDSCAPE; MUTATIONS; ACVR1;
D O I
10.1186/s40478-018-0652-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页数:6
相关论文
共 50 条
  • [1] A functional genomics approach to identify pathways of drug resistance in medulloblastoma
    Kelsey C. Bertrand
    Claudia C. Faria
    Patryk Skowron
    Amanda Luck
    Livia Garzia
    Xiaochong Wu
    Sameer Agnihotri
    Christian A. Smith
    Michael D. Taylor
    Stephen C. Mack
    James T. Rutka
    Acta Neuropathologica Communications, 6
  • [2] Functional genomics to identify unforeseen cancer drug targets
    Kemp, Christopher J.
    Grandori, Carla
    FUTURE ONCOLOGY, 2013, 9 (04) : 473 - 476
  • [3] Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics
    Lee, Alvin J. X.
    Swanton, Charles
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (08) : 1013 - 1020
  • [4] Functional genomics and cancer drug target discovery
    Moody, Susan E.
    Boehm, Jesse S.
    Barbie, David A.
    Hahn, William C.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (03) : 284 - 293
  • [5] Genomics and Cancer Drug Resistance
    Rodrigues, Antonio S.
    Dinis, Joana
    Gromicho, Marta
    Martins, Celia
    Laires, Antonio
    Rueff, Jose
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (05) : 651 - 673
  • [6] Drug resistance genomics of the antimalarial drug artemisinin
    Winzeler, Elizabeth A.
    Manary, Micah J.
    GENOME BIOLOGY, 2014, 15 (11):
  • [7] Overcoming multiple drug resistance mechanisms in medulloblastoma
    Ramadhan T Othman
    Ioanna Kimishi
    Tracey D Bradshaw
    Lisa CD Storer
    Andrey Korshunov
    Stefan M Pfister
    Richard G Grundy
    Ian D Kerr
    Beth Coyle
    Acta Neuropathologica Communications, 2
  • [8] Integrated genomics approach to identify biologically relevant alterations in fewer samples
    Chandrani, Pratik
    Upadhyay, Pawan
    Iyer, Prajish
    Tanna, Mayur
    Shetty, Madhur
    Raghuram, Gorantala Venkata
    Oak, Ninad
    Singh, Ankita
    Chaubal, Rohan
    Ramteke, Manoj
    Gupta, Sudeep
    Dutt, Amit
    BMC GENOMICS, 2015, 16
  • [9] Overcoming multiple drug resistance mechanisms in medulloblastoma
    Othman, Ramadhan T.
    Kimishi, Ioanna
    Bradshaw, Tracey D.
    Storer, Lisa C. D.
    Korshunov, Andrey
    Pfister, Stefan M.
    Grundy, Richard G.
    Kerr, Ian D.
    Coyle, Beth
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [10] Functional cloning as a means to-identify Leishmania genes involved in drug resistance
    Clos, J
    Choudhury, K
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (02) : 123 - 129